Delivery Order SPE2DB22D1106-SPE2DB24FDYJ4
Award Date 2/1/24
Potential Completion Date 2/2/24
Potential Value $6.7K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $10,268.58 for the provision of ROTARIX vaccine oral syringes. The award has a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor, and this order is fulfilled under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp valued at up to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a Firm Fixed Price Delivery Order contract by the Defense Logistics Agency (DLA) to provide 4,563,741,935 units of ROTARIX VACCINE ORAL SYRINGE 1.5ML. The contract has a potential value of $8,103.99 and a completion date of February 23, 2024. This order is issued under an Indefinite Delivery Contract (IDC) with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025....
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $35,895.00 Firm Fixed Price delivery order is for the supply of ROTARIX vaccine oral syringes (1.5 ML) and does not have a set-aside designation. Amerisourcebergen, as a major pharmaceutical distributor, has multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of critical...
- This is a $5,859.12 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ROTARIX VACCINE ORAL SYRINGE 1.5ML. The contract does not have a set-aside designation and has an ultimate completion date of April 2, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of ROTARIX VACCINE ORAL SYRINGE 1.5ML, a pharmaceutical product, for a firm fixed price of $29,581.50. The contract has a completion date of February 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA,...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $2,197.17 firm fixed-price delivery order placed by the Defense Logistics Agency (DLA) for the supply of ROTARIX vaccine oral syringes. The award, which has no set-aside designation, has an ultimate completion date of August 29, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
- This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the ROTARIX VACCINE ORAL SYRINGE 1.5ML. The $1,476.66 firm fixed price contract has a completion date of June 24, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the company to supply a wide range of pharmaceutical products and medical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $2,606.91 award is for the provision of ROTARIX VACCINE ORAL SYRINGE 1.5ML, with a completion date of March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. This...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $49,587.72, is for the provision of the ROTARIX vaccine oral syringe 1.5ML. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,654.02 firm fixed-price contract is for the delivery of the ROTARIX vaccine oral syringes (1.5 mL) and has an ultimate completion date of October 28, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FDYJ4Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $6,687.66 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide ROTARIX VACCINE ORAL SYRINGE 1.5ML. This award is part of an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp to deliver a comprehensive range of pharmaceutical products and medical supplies in support of military treatment programs and facilities worldwide. The IDC, valued up to $999,999,999.00, does not have any set-aside designations and was awarded solely to Amerisourcebergen Drug Corp as a single award contract.
Generated 5/2/24, 10:21 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 2/1/24 |